About
MabGenesis, Inc. is a biotech startup specializing in developing first-in-class and best-in-class therapeutic monoclonal antibody drugs for human and animal health, utilizing proprietary high-quality antibody libraries and monoclonal antibody isolation technologies.
Explore MabGenesis, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.